The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

ValiRx Completes YA Global Master Equity Swap Deal Early

Wed, 08th Oct 2014 15:31

LONDON (Alliance News) - Cancer diagnostics company ValiRx PLC Wednesday said its GBP1.5 million equity swap agreement with YA Global Master SPV Ltd has been completed early.

The company had announced the deal, which provided it with working capital alongside the GBP2.9 million it raised in a share placing at the same time, in December 2013, and Wednesday said it has been exercised in full.

YA Global Master has sold 206.5 million ValiRx shares. It still has an interest over 86.7 million ValiRx shares which are outside the terms of the swap agreement.

Under the original swap deal, YA Global Master was to made 18 monthly settlement payments of GBP83,333.33, in return for 753.8 million ValiRx shares.

ValiRx shares ended down 6.7% at 0.382 pence Wednesday.

By Steve McGrath; stevemcgrath@alliancenews.com; @stevemcgrath1

Copyright 2014 Alliance News Limited. All Rights Reserved.

Related Shares

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeu...

19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following lega...

12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.